Mon, Apr 14, 8:10 PM (31 days ago)
**Merit Medical Systems, Inc. (MMSI) 10-K/A Summary** **Company Overview:** Merit Medical Systems, Inc. (MMSI) filed an amendment (10-K/A) to its annual report to correct the five-year cumulative total return information for NASDAQ Stocks (SIC 3840-3849 U.S. Companies - Surgical, Medical and Dental Instruments and Supplies) in Part II, Item 5. The amendment does not modify other items or reflect subsequent events. **Market Information:** - **Ticker:** MMSI - **Exchange:** NASDAQ Global Select Market - **Outstanding Shares:** 58,834,568 as of February 21, 2025 - **Shareholders:** Approximately 90 shareholders of record - **Share Repurchases:** None during 2024, 2023, and 2022 - **Dividends:** None declared or paid; future dividends not anticipated due to earnings retention and regulatory/covenant restrictions. **Performance:** - **Stock Performance (2019-2024):** MMSI's stock value increased from $100 to $309.68, outperforming the NASDAQ US Benchmark TR Index and NASDAQ Stocks (SIC 3840-3849 U.S. Companies). **Certifications:** - **Executive Officers:** Fred P. Lampropoulos (President and CEO) and Raul Parra (CFO) certified the amendment, confirming no material misstatements or omissions. **Financial Condition and Outlook:** - The amendment does not provide updated financial statements or modify disclosures related to the company's financial condition or outlook. For the most recent financial information, refer to the initial 10-K filing. **Risk Factors:** - **Dividend Restrictions:** Cash held by the Chinese subsidiary and credit agreement covenants may prevent dividend payments. - **Market Performance:** Past performance is not indicative of future results.